The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: An immunohistochemical study of tissue microarrays

Anticancer Research

Volumn 28, Issue 2 A, 2008, Pages 1061-1067

  Li, Xiao Han ^a,b   Zheng, Hua Chuan ^b   Wang, Zhi Gang ^b   Takahashi, Hiroyuki ^a   Yang, Xiang Hong ^b   Guan, Yi Fu ^b   Takano, Yasuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Gastric carcinoma; MUC 1; Pathobiological behavior; Prognosis

Indexed keywords

MUCIN 1; MUCIN 2; MUCIN 4; MUCIN 5AC;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; STOMACH SURGERY; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MALE; MIDDLE AGED; MUCINS; PEPTIDE FRAGMENTS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 42549121600     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Inoue M and Tsugane S: Epidemiology of gastric cancer in Japan. Postgrad Med J 81: 419-424, 2005.
2. Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K and Takano Y: Up-regulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 95: 1371-1378, 2006.
3. Slomiany BL and Slomiany A: Impedance of Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis by peroxisome proliferator-activated receptor gamma activation involves phosphatidylinositol 3-kinase/ERK pathway. IUBMB Life 55: 97-102, 2003.
4. Slomiany BL and Slomiany A: Up-regulation in endothelin-1 by Helicobacter pylori lipopolysaccharide interferes with gastric mucin synthesis via epidermal growth factor receptor transactivation. Scand J Gastroenterol 40: 921-928, 2005.
5. Hollingsworth MA and Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45-60, 2004.
6. Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K and Takano Y: MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132: 817-823, 2006.
7. Cozzi PJ, Wang J, Delprado W, Perkins AC, Allen BJ, Russell PJ and Li Y: MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. Clin Exp Metastasis 22: 565-573, 2005.
8. Wang RQ and Fang DC: Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. J Clin Pathol 56: 378-384, 2003.
9. Akyürek N, Akyol G, Dursun A, Yamaç D and Günel N: Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis. Pathol Res Pract 198: 665-674, 2002.
10. Huang WB, Shi LH, Zhu XQ, Zhu XQ, Xu GX and Qi Q: Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance. Ai Zheng 21: 1231-1234, 2002.
11. Wang JY, Chang CT, Hsieh JS, Lee LW, Huang TJ, Chai CY and Lin SR: Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas. J Surg Oncol 83: 253-260, 2003.
12. Levi E, Klimstra DS, Andea A, Basturk O and Adsay NV: MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol 57: 456-462, 2004.
13. Fattorossi A, Battaglia A, Malinconico P, Stoler A, Andreocci L, Parente D, Coscarella A, Maggiano N, Perillo A, Pierelli L and Scambia G: Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells. Exp Cell Res 280: 107-118, 2002.
14. Wreschner DH, McGuckin MA, Williams SJ, Baruch A, Yoeli M, Ziv R, Okun L, Zaretsky J, Smorodinsky N, Keydar I, Neophytou P, Stacey M, Lin HH and Gordon S: Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins. Protein Sci 11: 698-706, 2002.
15. Pandey P, Kharbanda S and Kufe D: Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res 55: 4000-4003, 1995.
16. Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF and Ellis IO: Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 18: 1295-1304, 2005.
17. Yu LG, Andrews N, Zhao Q, McKean D, Williams JF, Connor LJ, Gerasimenko OV, Hilkens J, Hirabayashi J, Kasai K and Rhodes JM: Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 282: 773-781, 2007.
18. Sobin LH and Wittekind CH: TNM Classification of malignant tumors, 6th edn. New Jersey: John Wiley & Sons, Hoboken, 2002.
19. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K and Takano Y: Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 60: 273-277, 2007.
20. Kumada T, Tsuneyama K, Hatta H, Ishizawa S and Takano Y: Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17: 1141-1149, 2004.
21. Gaemers IC, Vos HL, Volders HH, van der Valk SW and Hilkens J: A stat-responsive element in the promoter of the episialin/MUC 1 gene is involved in its overexpression in carcinoma cells. J Biol Chem 276: 6191-6199, 2001.
22. Bieche I and Lidereau R: A gene dosage effect is responsible for high overexpression of the MUC1 gene observed in human breast tumors. Cancer Genet Cytogenet 98: 75-80, 1997.
23. Grohmann GP, Schirmacher P, Manzke O, Hanisch FG, Dienes HP and Baldus SE: Modulation of MUC1 and blood group antigen expression in gastric adenocarcinoma cells by cytokines. Cytokine 23: 86-93, 2003.
24. Lagow EL and Carson DD: Synergistic stimulation of MUC1 expression in normal breast epithelia and breast cancer cells by interferon-gamma and tumor necrosis factor-alpha. J Cell Biochem 86: 759-772, 2002.
25. Suwa T, Hinoda Y, Makiguchi Y, Takahashi T, Itoh F, Adachi M, Hareyama M and Imai K: Increased invasiveness of MUC1 and cDNA-transfected human gastric cancer MKN74 cells. Int J Cancer 76: 377-382, 1998.
26. Yamamoto M, Bharti A, Li Y and Kufe D: Interaction of the DF3/MUC1 breast carcinoma- associated antigen and beta-catenin in cell adhesion. J Biol Chem 272: 12492-12494, 1997.
27. Baldus SE, Zirbes TK, Engel S, Hanisch FG, Mönig SP, Lorenzen J, Glossmann J, Fromm S, Thiele J, Pichlmaier H and Dienes HP: Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer 79: 133-138, 1998.
28. Kocer B, Soran A, Kiyak G, Erdogan S, Eroglu A, Bozkurt B, Solak C and Cengiz O: Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci 49: 954-964, 2004.
29. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI and Kim WH: MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 92: 1427-1434, 2001.